Intermediate for Empagliflozin. Empagliflozin (trade name: Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2). Empagliflozin is used for the treatment of type 2 diabetes in adults. Empagliflozin has been approved by the U.S Food and Drug Administration on August 1, 2014.
Product Name: (2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone
CAS Number: 915095-86-2
Molecular Weight:  360.5536
Molecular Formula:  C13H7ClFIO
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.